Kidney disease hides. That is...
Kidney disease hides. That is probably its most clinically dangerous quality. There is no equivalent of chest pain - no symptom that sends a person urgently to a doctor while the damage is still reversible. Fatigue, some ankle swelling, a little froth in the urine on some mornings. Easy to ignore. By the time a creatinine result prompts a referral, quite often the kidneys are already running well below half their normal capacity, and the window for slowing the progression has partly closed.
Urology operates in a different register - more often acute, more often procedural. A stone causing obstruction, a prostate obstructing the bladder, a suspicious lesion on an incidental scan. All of it requires a surgeon who knows which procedures are appropriate, which can be avoided, and how to achieve the best outcome through the least invasive means currently available.
Medanta The Medicity, Gurugram brings both specialities together under one department, with a team that covers the full clinical spectrum from early-stage CKD management to ABO-incompatible kidney transplantation, from endourology for stones to robotic radical cystectomy with intracorporeal diversion. It is a large team, with depth in each subspecialty area rather than a generalist coverage across all of them.
Nephrology - Medical Management of Kidney Disease
Dr. Shyam Bihari Bansal is Vice Chairman of the department. His DM in Nephrology sits alongside an MD and an FRCP - the Fellowship of the Royal Colleges of Physicians UK, a qualification that requires structured postgraduate training and examination to a standard recognised internationally. Kidney transplantation is a central part of his practice, including the more complex end of the transplant spectrum: ABO-incompatible cases, where the donor and recipient have mismatched blood groups, and HLA-incompatible transplants. Both require desensitisation before surgery and careful immunological management afterward. Beyond transplant, his work spans haemodialysis, CAPD, hemodiafiltration, CRRT in critical care, acute kidney injury, CKD, and the full range of glomerular diseases like IgA nephropathy, membranous nephropathy, SLE nephritis, and vasculitis.
Dr. Debabrata Mukherjee trained at two institutions not known for producing ordinary clinicians. His MBBS and MD came from AFMC Pune the Armed Forces Medical College, where selection is competitive and the clinical training rigorous. His DM in Nephrology is from PGIMER Chandigarh, one of the busiest nephrology training programmes in the country. He has been involved in shaping national policy on CKD. Day to day, his practice focuses on interventional nephrology creating AV fistulas for dialysis access, inserting CAPD catheters and permcaths, performing kidney biopsies alongside complex and cadaveric renal transplant.
Dr. Manish Jain, Senior Director, holds a DM in Nephrology and a fellowship, and manages adult nephrology, renal replacement therapy, and transplantation.
Urology - Surgical and Robotic Urological Care
Dr. Gagan Gautam trained in minimally invasive urology through a clinical fellowship after his MCh, and has built a practice centred almost entirely on urological cancers lik prostate, kidney, bladder, penile, testicular, adrenal.
Dr. Sanjay Gogoi did his MCh at SGPGIMS Lucknow, which has one of the more established urology training programmes in North India. His scope is deliberately broad: kidney transplant, uro-oncology, robotic procedures, reconstructive urology, and paediatric urology, the kind of range that takes years of varied clinical exposure to build.
Dr. Prasun Ghosh's particular focus is robotic and minimally invasive urology, including robotic-assisted renal transplantation (a procedure that removes the need for the large open incision of conventional transplant) and endourology for stones, prostate, and bladder conditions.
Dr. Puneet Ahluwalia leads the department's robotic uro-oncology programme. His MCh in Urology is supplemented by fellowship training specifically in robotic urology and advanced robotic surgery. His work includes robotic radical prostatectomy, robotic radical cystectomy with intracorporeal urinary diversion (where the new urinary reservoir is constructed inside the body rather than through a separate abdominal wound), and robotic partial and radical nephrectomy for kidney cancer.
Dr. Deepak Kumar Rathi, Associate Director, holds a Fellowship in Robotics and Renal Transplantation and covers endourology, uro-oncology, laparoscopic and robotic urological surgery, and transplant.
Dr. Amita Jain, Associate Director, focuses on urogynaecology including robotic cystoscopic procedures, vaginal surgery, conservative non-surgical treatment, and diagnostic urogynaecology.
My creatinine has been slightly elevated for a year. Do I need to see a nephrologist?
Probably, yes. One slightly elevated creatinine reading is easy to explain away like dehydration, a heavy protein meal the night before, a temporary illness. Twelve months of it is something else. A nephrologist does not just look at the creatinine they calculate your eGFR, interpret urine microscopy, and piece together whether you have early stable CKD that needs monitoring or progressive disease that needs active management now. The distinction matters because the window for slowing progression is real, and it closes.
What is robotic-assisted kidney transplant and how does it differ from conventional transplant?
Open kidney transplant involves a long incision in the lower abdomen to place the donor kidney in the pelvis. Robotic transplant does the same thing through small keyhole ports, with the surgeon working at a console rather than directly in the wound. Less blood loss, a smaller scar, fewer wound complications, faster recovery.
What does an ABO-incompatible kidney transplant mean?
Standard kidney transplantation requires the donor and recipient to share a compatible blood group. ABO-incompatible transplant breaks that rule. A blood group B patient with a blood group A spouse who wants to donate that would previously have been impossible. Now it is not, at centres that have the protocol and experience to do it safely. The preparation involves removing pre-existing antibodies against the donor blood group, usually through plasmapheresis, and suppressing their production through targeted immunotherapy. Surgery then proceeds, followed by close monitoring for antibody-mediated rejection in the early post-transplant period. It expands who can receive a living donor kidney, which matters considerably in a country where deceased donor rates remain low. Not every nephrology unit offers it. At Medanta Gurugram, both Dr. Bansal and Dr. Mukherjee manage these cases.